Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study
Objective: To evaluate three-year outcomes from the ND0612 BeyoND study. Background: Investigational ND0612 is in development as a 24-hour continuous, subcutaneous infusion of liquid levodopa/carbidopa…A novel mobile application for monitoring the response to botulinum toxin in patients with Cervical Dystonia.
Objective: A pilot study to determine the acceptability of a novel DystoniaDiary application in patients with Cervical Dystonia (CD) attending a specialist clinic. Background: The…Disorder of bulk lipid transfer? Lipid composition and distribution in cellular models of VPS13A disease
Objective: To study the overall lipid composition and distribution in red blood cells (RBCs) and neurons derived from VPS13A disease patients, a neurodegenerative disorder associated…The effect of peptic ulcer disease on Parkinson’s disease
Objective: To compare patients with Parkinson’s disease (PD, PwP) with and without peptic ulcer disease (PUD) regarding cognition, psychiatric status, motor and non-motor symptoms, mobility,…Publication rates and characteristics of clinical trials in deep brain and responsive neurostimulation
Objective: We examine DBS and RNS trials from 1997-2022, chart their characteristics, and examine rates and predictors of results reporting. Background: Prompt dissemination of clinical…Can the Ohm’s law predict the amplitude of neurostimulation when adapting systems in deep brain stimulation?
Objective: Review and analysis of clinical and neurostimulation parameters in patients with replacement of constant-voltage non-rechargeable implantable pulse generator (CV-nrIPG) by constant-current rechargeable IPG (CC-rIPG)…Preliminary Report on the Safety and Tolerability of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for Parkinson’s disease: Phase IIa double-blind, randomized controlled trial
Objective: To select the safest and most effective number of repeat doses of allogeneic mesenchymal stem cells (MSC) purified from bone marrow-derived from a healthy…Recruiting people at risk of Parkinson’s disease: comparative data from PPMI Online and HeBA Kassel
Objective: To compare a US- and Germany-based staged screening process to identify people at risk of developing Parkinson’s disease (PD). Background: The Parkinson’s Progression Marker…Using mediation analysis to account for the effect of Parkinson’s Disease medications on disease progression
Objective: To explore the use of mediation analysis to incorporate L-dopa equivalent daily dose (LEDD) for disease progression of Parkinson’s Disease (PD) in a simulation…The Dystonic Drive – A Systematic Review on Coherence Analysis in Dystonia
Objective: To perform a systematic review on coherence analysis in dystonia. We focus on different modalities and describe the relation of abnormal coherent frequency bands…
- « Previous Page
- 1
- …
- 395
- 396
- 397
- 398
- 399
- …
- 1734
- Next Page »